Cargando…

Correction to: Analysis of cardiac monitoring and safety data in patients initiating fingolimod treatment in the home or in clinic

Detalles Bibliográficos
Autores principales:	Brown, Brandon, Weiss, Jamie L., Kolodny, Scott, Meng, Xiangyi, Williams, Ian M., Osborne, John A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925476/ https://www.ncbi.nlm.nih.gov/pubmed/31864306 http://dx.doi.org/10.1186/s12883-019-1568-z

Ejemplares similares

Analysis of cardiac monitoring and safety data in patients initiating fingolimod treatment in the home or in clinic
por: Brown, Brandon, et al.
Publicado: (2019)

Lymphocyte counts and infection rates: Long-term fingolimod treatment in primary progressive MS
por: Fox, Edward J., et al.
Publicado: (2019)

Immune cell subset profiling in multiple sclerosis after fingolimod initiation and continued treatment: The FLUENT study
por: Mao-Draayer, Yang, et al.
Publicado: (2022)

Modulation of Cardiac Autonomic Function by Fingolimod Initiation and Predictors for Fingolimod Induced Bradycardia in Patients with Multiple Sclerosis
por: Li, Kai, et al.
Publicado: (2017)

The FLUENT study design: investigating immune cell subset and neurofilament changes in patients with relapsing multiple sclerosis treated with fingolimod
por: Cohen, Jeffrey A, et al.
Publicado: (2019)

Dramatic rebounds of MS during pregnancy following fingolimod withdrawal
Publicado: (2018)

Characterization of lymphopenia in patients with MS treated with dimethyl fumarate and fingolimod
Publicado: (2018)

Correction: Prophylactic versus Therapeutic Fingolimod: Restoration of Presynaptic Defects in Mice Suffering from Experimental Autoimmune Encephalomyelitis
por: Bonfiglio, Tommaso, et al.
Publicado: (2023)

Neurological safety of fingolimod: An updated review
por: Yoshii, Fumihito, et al.
Publicado: (2017)

Intermittent Atrioventricular Block following Fingolimod Initiation
por: Gialafos, E., et al.
Publicado: (2014)

Phase IV study of retention on fingolimod versus injectable multiple sclerosis therapies: a randomized clinical trial
por: Cree, Bruce A.C., et al.
Publicado: (2018)

Efficacy and Safety of Fingolimod in an Unselected Patient Population
por: Rasenack, Maria, et al.
Publicado: (2016)

Author Correction: Fingolimod-induced decrease in heart rate may predict subsequent decreasing degree of lymphocytes
por: Ikeda, Tokunori, et al.
Publicado: (2019)

Correction: Low-cost solution for rodent home-cage behaviour monitoring
Publicado: (2019)

Electrocardiographic assessments and cardiac events after fingolimod first dose – a comprehensive monitoring study
por: Limmroth, Volker, et al.
Publicado: (2017)

Correction to: Monitoring Quality Across Home Visiting Models: A Field Test of Michigan’s Home Visiting Quality Assurance System
por: Heany, Julia, et al.
Publicado: (2018)

Determination of Seminal Concentration of Fingolimod and Fingolimod‐Phosphate in Multiple Sclerosis Patients Receiving Chronic Treatment With Fingolimod
por: David, Olivier J., et al.
Publicado: (2017)

Correction: Effects of home-based cardiac exercise rehabilitation with remote electrocardiogram monitoring in patients with chronic heart failure: a study protocol for a randomised controlled trial
Publicado: (2020)

Correction to: Cost Effectiveness of Ambulatory Blood Pressure Monitoring Compared with Home or Clinic Blood Pressure Monitoring for Diagnosing Hypertension in Australia
por: Shah, Karan K., et al.
Publicado: (2022)

A Comprehensive Monitoring Study on Electrocardiographic Assessments and Cardiac Events After Fingolimod First Dose—Possible Predictors of Cardiac Outcomes
por: Limmroth, Volker, et al.
Publicado: (2020)

Correction: Development and psychometric assessment an instrument for investigating Women’s attitude toward home safety
por: Ahmadpour-geshlagi, Rasoul, et al.
Publicado: (2022)

Correction to: Work from Home and Daily Time Allocations: Evidence from the Coronavirus Pandemic
por: Restrepo, Brandon J., et al.
Publicado: (2022)

Safety and Efficacy of Fingolimod in Treatment-Naïve Multiple Sclerosis Patients
por: Marriott, James J.
Publicado: (2011)

Fingolimod Real World Experience: Efficacy and Safety in Clinical Practice
por: Fonseca, Joaquim
Publicado: (2015)

Functional Connectivity Changes After Initial Treatment With Fingolimod in Multiple Sclerosis
por: Petsas, Nikolaos, et al.
Publicado: (2019)

Correction: Burn Injury-Specific Home Safety Assessment: A Cross-Sectional Study in Iran
por: Arshi, Shahnam, et al.
Publicado: (2013)

Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study
por: Gold, Ralf, et al.
Publicado: (2013)

Correction: Prediction of atrial fibrillation using a home blood pressure monitor with a high-resolution system
Publicado: (2023)

Safety and Efficacy of Fingolimod in Iranian Patients with Relapsing-remitting Multiple Sclerosis
por: Yavari, Fatemeh, et al.
Publicado: (2021)

Correction to: Differences in assistive technology installed for people with dementia living at home who have wandering and safety risks
por: Curnow, Eleanor, et al.
Publicado: (2022)

Omitted Information on Data and Safety Monitoring Board
Publicado: (2022)

Correction: On the Potential of Surfers to Monitor Environmental Indicators in the Coastal Zone
por: Brewin, Robert J. W., et al.
Publicado: (2016)

Correction: Monitoring of Non-communicable Diseases in a Primary Healthcare Setting in India: A Quality Improvement Initiative
por: Chandra, Ankit, et al.
Publicado: (2023)

Correction to: Two-stage Bayesian hierarchical modeling for blinded and unblinded safety monitoring in randomized clinical trials
por: Liu, Junhao, et al.
Publicado: (2020)

Cardiac repolarization during fingolimod treatment in patients with relapsing–remitting multiple sclerosis
por: Laiho, Aapo, et al.
Publicado: (2018)

Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis
por: Gajofatto, Alberto, et al.
Publicado: (2015)

Long-term safety and real-world effectiveness of fingolimod in relapsing multiple sclerosis
por: Druart, Charlotte, et al.
Publicado: (2017)

Efficacy and Safety of Fingolimod in Daily Practice: Experience of an Academic MS French Center
por: Roux, Thomas, et al.
Publicado: (2017)

Clinical effectiveness and safety of fingolimod in relapsing remitting multiple sclerosis in Western Iran
por: Ouspid, Elham, et al.
Publicado: (2018)

Antidepressant activity of fingolimod in mice
por: di Nuzzo, Luigi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_d9nlh3brmp8kkekce834ih4954